Catalyst Wire Dossier Catalyst Wire Dossier

SOLIRIS

eculizumab · Alexion Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

60 regulatory and trial events tracked for SOLIRIS, covering 2007-02-21 to 2026-02-19. Get the full timeline:

Most recent: EMA Authorised: Soliris (Eculizumab) — Alexion Europe SAS

See pricing